187.06
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                Forum
                                Previsione
                                    Frazionamento azionario
                                    Storia dei dividendi
                        
                            Ligand Pharmaceuticals Inc Azioni (LGND) Dati Finanziari
Conto economico
                
            Trimestrale
                
            
        *Tutti i numeri sono espressi in milioni
    
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 
| Revenues | 
                                            
                                        5.06%
                                     47.63 | 45.33 | 42.81 | 51.81 | 41.53 | 
|  | 
                                            
                                        51.95%
                                     39.18 | 81.55 | 52.45 | 48.67 | 60.63 | 
| Benefits Costs and Expenses | 
                                            
                                        61.89%
                                     36.40 | 95.51 | 82.01 | 58.15 | 106.92 | 
| Costs And Expenses | 
                                            
                                        61.89%
                                     36.40 | 95.51 | 82.01 | 58.15 | 106.92 | 
| Operating Income/Loss | 
                                            
                                        123.32%
                                     8.444 | -36.22 | -9.637 | 3.143 | -19.10 | 
| Nonoperating Income/Loss | 
                                            
                                        119.90%
                                     2.779 | -13.96 | -29.56 | -9.482 | -46.29 | 
| Income/Loss From Equity Method Investments | - | - | -1.245 | -1.194 | -8.03 | 
| Income/Loss From Continuing Operations Before Tax | 
                                            
                                        122.37%
                                     11.22 | -50.18 | -39.20 | -6.339 | -65.39 | 
| Income Tax Expense/Benefit | 
                                            
                                        182.49%
                                     6.376 | -7.729 | -8.112 | 0.833 | -13.48 | 
| Income/Loss From Continuing Operations After Tax | 
                                            
                                        111.42%
                                     4.847 | -42.45 | -31.09 | -7.172 | -51.91 | 
|  | 
                                            
                                        111.42%
                                     4.847 | -42.45 | -31.09 | -7.172 | -51.91 | 
| Preferred Stock Dividends And Other Adjustments | - | - | - | - | - | 
| Attributable To Noncontrolling Interest | - | - | - | - | - | 
| Basic Average Shares | 
                                            
                                        0.71%
                                     19.33 | 19.19 | 0.229 | 18.42 | 18.03 | 
| Diluted Average Shares | 
                                            
                                        3.83%
                                     19.93 | 19.19 | -0.284 | 18.42 | 18.03 | 
| Basic Earnings Per Share | 
                                            
                                        111.31%
                                     0.25 | -2.21 | -1.72 | -0.39 | -2.88 | 
| Diluted Earnings Per Share | 
                                            
                                        110.86%
                                     0.24 | -2.21 | -1.68 | -0.39 | -2.88 | 
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | - | - | - | - | - | 
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):
                 
            
         
                     
                             Scarica l'app Stockscreener
                    Scarica l'app Stockscreener
                